Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Medical Prognosis Institute AS (MPI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7027
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurposing, patient selection, drug combinations, pathway elucidation, new indications, indication selection and companion diagnostic programs. MPI also offers drug specific interface to the human genome and predict drug response in individual patients. The company has partnerships with various cancer drug developing companies. It operates in Denmark and the US. MPI is headquartered in Horsholm, Denmark.

Medical Prognosis Institute AS (MPI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medical Prognosis Institute A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medical Prognosis Institute A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medical Prognosis Institute A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medical Prognosis Institute A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Medical Prognosis Institute A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Medical Prognosis Institute A/S, Medical Equipment, Deal Details 10
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 10
Equity Offering 11
Medical Prognosis Institute Raises USD1.2 Million in Rights Offering of Shares 11
Medical Prognosis Raises USD1.7 Million in Rights Issue of Shares 12
Medical Prognosis Institute A/S – Key Competitors 13
Medical Prognosis Institute A/S – Key Employees 14
Medical Prognosis Institute A/S – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Mar 23, 2018: MPI publishes Annual report for 2017 16
Mar 13, 2018: Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 – 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture 19
Aug 31, 2017: MPI publishes Half-year Report for the first half of 2017 20
Mar 31, 2017: MPI publishes Annual Report for 2016 22
Corporate Communications 23
May 31, 2018: MPI – Change in Board of directors 23
Other Significant Developments 24
Jul 02, 2018: MPI – Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients – Collaborative LiPlaCis Regulatory Meeting with DKMA 24
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Medical Prognosis Institute A/S, Medical Equipment, Key Facts, 2017 2
Medical Prognosis Institute A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Medical Prognosis Institute A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medical Prognosis Institute A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medical Prognosis Institute A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medical Prognosis Institute A/S, Deals By Market, 2012 to YTD 2018 8
Medical Prognosis Institute A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 10
Medical Prognosis Institute Raises USD1.2 Million in Rights Offering of Shares 11
Medical Prognosis Raises USD1.7 Million in Rights Issue of Shares 12
Medical Prognosis Institute A/S, Key Competitors 13
Medical Prognosis Institute A/S, Key Employees 14
Medical Prognosis Institute A/S, Subsidiaries 15

List of Figures
Medical Prognosis Institute A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Medical Prognosis Institute A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Medical Prognosis Institute A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Medical Prognosis Institute A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Medical Prognosis Institute A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medical Prognosis Institute A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Medical Prognosis Institute A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medical Prognosis Institute A/S, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DaVita Inc (DVA):医療機器:M&Aディール及び事業提携情報
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • Compass Group PLC:戦略・SWOT・企業財務分析
    Compass Group PLC - Strategy, SWOT and Corporate Finance Report Summary Compass Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • UnitedHealth Group Inc (UNH)-製薬・医療分野:企業M&A・提携分析
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • Sanghi Industries Limited:企業の戦略・SWOT・財務情報
    Sanghi Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Sanghi Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Goldcorp Inc:企業のM&A・事業提携・投資動向
    Goldcorp Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goldcorp Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Kansas City Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Kansas City Power & Light Co. (KCP&L), a subsidiary of Great Plains Energy, Inc., is an integrated energy utility that generates, transmits, distributes, and sells electricity. The company generates electricity from nuclear, solar, biogas, wind, hydro, coal, and natural gas sources. Through …
  • Fujifilm SonoSite Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • China Petrochemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China Petrochemical Corp (Sinopec Corp) is a petroleum and petrochemical company. The company is engaged in the engaged in the exploration and production, pipeline transportation, and sale of petroleum and natural gas. It is also involved in the production, sale, storage and transportation o …
  • Takeda Pharmaceutical Co Ltd (4502):企業の財務・戦略的SWOT分析
    Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Virgin Australia Holdings Limited:企業のM&A・事業提携・投資動向
    Virgin Australia Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Australia Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Hotel Properties Ltd:企業の戦略・SWOT・財務情報
    Hotel Properties Ltd - Strategy, SWOT and Corporate Finance Report Summary Hotel Properties Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Destiny Pharma Plc (DEST):製薬・医療:M&Aディール及び事業提携情報
    Summary Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development of the antibacterial products. The company provides XF drug platform to addre …
  • Genomind Inc-医療機器分野:企業M&A・提携分析
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing products. The company’s product portfolio includes The Genecept Assay, a genetic test developed for clinicians to optimize treatment decisions for their patients with mental illness. Its assay finds pati …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • University of California Los Angeles-医療機器分野:企業M&A・提携分析
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduat …
  • Westdeutsche Immobilien Servicing AG:企業の戦略・SWOT・財務分析
    Westdeutsche Immobilien Servicing AG - Strategy, SWOT and Corporate Finance Report Summary Westdeutsche Immobilien Servicing AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Mersen SA (MRN):電力:M&Aディール及び事業提携情報
    Summary Mersen SA (Mersen), formerly known as Groupe Carbone Lorraine SA, is a manufacturer of electrical power and advanced materials. It design and innovate solutions to address its clients need in specific markets. The company’s product portfolio comprises solutions such as carbon products, graph …
  • Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • SurModics Inc (SRDX):医療機器:M&Aディール及び事業提携情報
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆